Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) is anticipated to release its earnings data before the market opens on ...
Short interest in Atos SE (OTC:AEXAF ... of this short interest to close out their positions without sending the stock sharply higher.
Paris, France - March 7, 2025. – Atos SE (the “Company”) announces the implementation of a reverse stock split of the shares comprising its share capital, through the exchange of 10,000 old ...
ATOSSA GENETICS ($ATOS) posted quarterly earnings results on Tuesday, March 25th. The company reported earnings of -$0.05 per share, beating estimates of -$0.06 by $0 ...
Equities research analysts at HC Wainwright increased their Q1 2025 earnings estimates for Atossa Therapeutics in a note ...
The stock split will start on March 25 and will end on April 23, Atos said in a statement. The company is consolidating its ...
Zacks Investment Research on MSN4d
All You Need to Know About Atossa Genetics (ATOS) Rating Upgrade to BuyAtossa Genetics Inc. (ATOS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...
Paris, France - March 7, 2025. – Atos SE (the “Company”) announces the implementation of a reverse stock split of the shares comprising its share capital, through the exchange of 10,000 old shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback